Q3 2025 Holdings
Filed 2025-11-14 | 93 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $105.3M | 142,750 | 6.2% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $80.4M | 105,400 | 4.7% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $72.4M | 717,102 | 4.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $63.2M | 137,746 | 3.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $62.4M | 1,335,270 | 3.6% |
| Merus N V | COM | N5749R100 | $56.2M | 597,051 | 3.3% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $55.8M | 761,126 | 3.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $55.4M | 385,000 | 3.2% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $51.7M | 2,164,773 | 3.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $42.6M | 214,500 | 2.5% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $40.4M | 235,000 | 2.4% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $38.5M | 958,542 | 2.2% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $37.5M | 1,246,341 | 2.2% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $36.7M | 82,000 | 2.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $35.2M | 360,250 | 2.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $34.2M | 851,744 | 2.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $33.9M | 74,250 | 2.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $32.5M | 593,500 | 1.9% |
| Penumbra Inc(PEN) | COM | 70975L107 | $30.5M | 120,500 | 1.8% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $29.7M | 626,526 | 1.7% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $29.6M | 794,133 | 1.7% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $26.8M | 791,193 | 1.6% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $26.6M | 951,154 | 1.6% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $25.5M | 450,374 | 1.5% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $25.4M | 125,000 | 1.5% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $25.0M | 2,950,000 | 1.5% |
| Caris Life Sciences Inc(CAI) | COM | 142152107 | $24.0M | 793,651 | 1.4% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $23.9M | 249,402 | 1.4% |
| Dexcom Inc(DXCM) | COM | 252131107 | $21.3M | 316,900 | 1.2% |
| Omada Health Inc(OMDA) | COM | 68170A108 | $20.3M | 919,950 | 1.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $18.7M | 721,538 | 1.1% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $17.9M | 617,396 | 1.0% |
| Phreesia Inc(PHR) | COM | 71944F106 | $17.6M | 749,116 | 1.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $17.1M | 288,344 | 1.0% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $16.9M | 595,929 | 1.0% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $15.7M | 4,474,702 | 0.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $15.6M | 623,402 | 0.9% |
| Azenta Inc(AZTA) | COM | 114340102 | $15.5M | 540,400 | 0.9% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $15.5M | 408,313 | 0.9% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $15.3M | 1,947,374 | 0.9% |
| Spdr Series Trust(XBI) | S&P BIOTECH | 78464A870 | $15.2M | 151,750 | 0.9% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $14.7M | 178,982 | 0.9% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $14.7M | 710,000 | 0.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $14.5M | 1,008,308 | 0.8% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $14.0M | 686,107 | 0.8% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $12.9M | 580,677 | 0.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $12.6M | 89,750 | 0.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $12.6M | 2,286,273 | 0.7% |
| Danaher Corporation(DHR) | COM | 235851102 | $12.2M | 61,500 | 0.7% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $11.0M | 236,227 | 0.6% |